Fabentech

French Biotech developing breakthrough immunotherapies to address situations of emergency

[Direction générale de l'armement 🇫🇷 @DGA]

@fabentech @Armees_Gouv ↪️ Fabentech démarre la livraison de ses premières doses pour les armées et l’export 🇪🇺, avec le soutien de la DGA via le dispositif régime d’appui �� l’innovation duale pour les PME #RAPID

[Fabentech @fabentech]

Merci Madame la Ministre @CaVautrin pour votre soutien.
Cette réussite illustre la force du partenariat public-privé au service de l’intérêt général, fondé sur la confiance, l’excellence scientifique et l’engagement des armées aux côtés de l’innovation française.

[Catherine Vautrin @CaVautrin]

Je salue le succès de Fabentech qui vient d’obtenir l’autorisation de mise sur le marché de son antidote contre la ricine, première mondiale dans ce domaine, illustration de la capacité des armées à accompagner l’innovation et à faire émerger des partenariats solides avec les entreprises de nos territoires. Une réussite française qui conjugue excellence industrielle et intérêt général.

[Fabentech @fabentech]

Lire le communiqué : https://t.co/GnO6DbZcAt

[Fabentech @fabentech]

Information médias & investisseurs

Obtention de l’AMM pour Ricimed®, premier antidote autorisé contre l’intoxication à la ricine — une menace biologique majeure.
Ce jalon renforce le positionnement de Fabentech comme acteur européen de référence en contremesures médicales.

[Fabentech @fabentech]

🎙️Sébastien IVA était invité sur le plateau de @BFMLyon à l’occasion de l’obtention d’un financement de 20 millions d’euros accordé par la Banque Européenne d’Investissement, via le mécanisme HERA Invest.
@EIB @EC_HERA

👇👇
Replay à 2min41
https://t.co/T863fh8pIf

[Commission européenne 🇪🇺 @UEFrance]

Nous signons aujourd'hui via @EC_HERA & @EIB un accord HERA Invest d'une valeur de 20 M€ avec @Fabentech 🇫🇷

Il permettra à l'entreprise de mettre au point & déployer ses médicaments à large spectre afin de lutter contre les menaces biologiques pour la santé publique ����

[European Investment Bank @EIB]

🇫🇷🇪🇺 Investing in innovative biotech companies is essential to strengthen health security in Europe.

We are joining forces with @EC_HERA and French biopharmaceutical company @fabentech to advance preparedness against pandemics and biological threats⤵️

https://t.co/7w7QqnWCHQ

[EU HERA @EC_HERA]

1st #HERAInvest Ioan signed with @fabentech & @EIB to advance the development of broad-spectrum therapeutics against cross-border health threats. A vital step in fostering innovation & preparedness for public health emergencies with a €20M investment
➡️🔗https://t.co/IsXiCjKph2

[Fabentech @fabentech]

Thanks @EC_HERA and @EIB for your trust and support in helping us to combat biological threats.

[Fabentech @fabentech]

@LaurentMuschel,director of @EC_HERA at the media conference organized by fabentech to announce €20m financing by the @EIB through the HERA invest mechanism.

[Fabentech @fabentech]

📢@Fabentech is thrilled to announce it will receive €20 million in financing to advance #Preparedness against #BiologicalThreats, allocated by the European Investment Bank @EIB through the @EC_HERA Invest programme!

Read our press release at https://t.co/ECOMpjjW03

[Fabentech @fabentech]

🎙️Great presentation of Caroline Ballet at the 6th Edition of the #WorldCongressOnInfectiousDiseases!

Caroline took the stage and shared the findings of Epic Crown 2 project. These results demonstrate the broadly neutralizing activity of #polyclonalantibody fragments.

[Fabentech @fabentech]

📢 Great achievement! Fabentech is thrilled to announce the launch and first results of first-in-human clinical trial for a antidote against a deadly plant-based toxin!

🔎To discover more about this exciting news, visit our linkedin post 👇: https://t.co/jh3JruEcku

[EU HERA @EC_HERA]

Great discussion on health preparedness at @NATO HQ today! Head of HERA @LaurentMuschel had a productive exchange with NATO officials. A pleasure to see Dr Raed Arafat again! Together, we're better prepared to tackle global health challenges #NATO #HealthPreparedness #HERA

[Fabentech @fabentech]

🤝 Ready to connect and discover more about Fabentech lifesaving solutions against biological threats?
Come and meet Sébastien IVA, CEO, and Grégory Vernier, Ph.D., Head of Business Development, who will attend the BIO International Convention in San Diego from June 3th to 6th!

[EU HERA @EC_HERA]

WHO publishes the Bacterial Priority Pathogens List, incl. 15 families of antibiotic resistant pathogens, grouped into categories of priority for R&D.

HERA's glad to support @WHO for this prioritisation work, guiding 🌍 R&D and investment against #AMR

👉https://t.co/kYdixDGva6

[Fabentech @fabentech]

💊 Fabentech was present at the launch of the Critical Medicines Alliance, a pioneering initiative!
We're dedicated to contributing to this essential cause, collaborating closely with European stakeholders to strengthen health security and resilience against #biologicalthreats.

[EU HERA @EC_HERA]

The Critical Medicines Alliance is launched!

The Alliance will work to identify the best measures to address and avoid shortages of critical medicines.

More info 👇👉 https://t.co/3L5hiPTEms

[Fabentech @fabentech]

✨ Sébastien Iva will attend the @EC_HERA Info Days, and represent @fabentech expertise and ambition together with stakeholders of #healthpreparedness and response in Europe !

🗓 April, 18th 2024
📍Paris, France

More about the HERA Info Days : https://t.co/4qObMllAe9

[Fabentech @fabentech]

@fabentech stands ready to deploy FabenFLU®, a fully-developed treatment designed to combat potential epidemics from the #AvianFlu virus.
FabenFLU® showed broad neutralizing activity against a vast range of 20 virus clades, reinforcing the potency of polyclonal approach.

[ECDC @ECDC_EU]

#JustPublished:
Understanding #AvianInfluenza pandemic drivers crucial in reducing risks to human health - say @ECDC_EU & @EFSA_EU in a joint report.

Read more: https://t.co/plM9ASw7Li

[Fabentech @fabentech]

Découvrez l’intervention de Sébastien Iva, CEO de @fabentech, au Global Industrie. A retenir:

👉 notre ambition de devenir le leader européen des immunothérapies d’urgence
👉le besoin d’un bouclier européen et souverain contre les menaces biologiques

https://t.co/kQVD2vmZtZ